City of Hope Medical Center: all 674 studies

Page 4 of 7. Open to participants first (178), then studies with results posted, then the rest; newest registration first within each.

• Epigenetic Signature for CRC Early DetectionActive, not recruitingNCT07224854
• Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic TargetingCompletedNCT07224802
• Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.CompletedNCT07224737
• Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane ChemotherapyCompletedNCT07218718Not applicable
• RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyWithdrawnNCT07218692Phase 2
• Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast CancerWithdrawnNCT07136493Not applicable
• Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System LymphomaSuspendedNCT06922604Phase 1
• Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related LymphedemaWithdrawnNCT06672224Not applicable
• Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal CancerCompletedNCT06654622
• STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWithdrawnNCT06626256Phase 1
• On the BRINK: PhotoBiomodulation (PBM) for Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell TRansplant (HSCT) - Implementing the Evidence & Discovering New KnowledgeActive, not recruitingNCT06625619
• Aromatherapy Oil Associated for Managing Anxiety and Pain During Bone Marrow Biopsy ProceduresSuspendedNCT06581211Not applicable
• [18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate CancerActive, not recruitingNCT06580015Not applicable
• Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal CancerWithdrawnNCT06575725Phase 2
• Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular LymphomaSuspendedNCT06575686Phase 2
• Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched DonorWithdrawnNCT06572631Phase 1
• External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary DiseaseSuspendedNCT06572605Phase 1/2
• Biology-Guided Radiation Therapy for the Treatment of Patients With Bone MetastasesSuspendedNCT06549478Phase 1
• High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast CancerSuspendedNCT06538389Phase 2
• Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer SurvivorsSuspendedNCT06500377Not applicable
• Predicting the Efficacy in Advanced Gastric Cancer.CompletedNCT06490055
• Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid LeukemiaSuspendedNCT06454409Phase 1
• Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic LeukemiaSuspendedNCT06447987Phase 1
• Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)CompletedNCT06381648
• A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal AdenocarcinomaCompletedNCT06381583
• Stomach Cancer Exosome-based DetectionCompletedNCT06342427
• Lung Cancer Risk Assessment and EtiologyCompletedNCT06328621
• Predicting Local and Distant Recurrence in T1 Colorectal CancerCompletedNCT06314971
• Early-Onset Colorectal Cancer RecurrenceCompletedNCT06271980
• Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic SyndromeSuspendedNCT06195891Phase 1
• Passive Music Intervention for the Reduction of Anxiety in Patients Undergoing Bone Marrow Aspiration and/or BiopsyActive, not recruitingNCT06169267Phase 3
• Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast CancerActive, not recruitingNCT06130826Phase 1
• Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular LymphomaActive, not recruitingNCT06112847Phase 2
• Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell CarcinomaSuspendedNCT06049576Phase 1
• Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung CarcinomaSuspendedNCT06014827Phase 2
• Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst CaActive, not recruitingNCT06008158Phase 2
• Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell TransplantationSuspendedNCT05993611Phase 1
• Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of CancerActive, not recruitingNCT05868486Early Phase 1
• Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell LymphomaSuspendedNCT05861050Phase 1/2
• RefleXion PET/CT Imaging Performance in Patients With Various MalignanciesActive, not recruitingNCT05844306Not applicable
• Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung CancerWithdrawnNCT05840770Phase 2
• Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDSWithdrawnNCT05823480Phase 1
• e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot StudyActive, not recruitingNCT05786456Not applicable
• Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with GlioblastomaWithdrawnNCT05773664Phase 1
• 64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body RadiationWithdrawnNCT05728372Early Phase 1
• Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal CancersActive, not recruitingNCT05722288Phase 2
• Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL StudyActive, not recruitingNCT05718869Phase 2
• CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First RemissionActive, not recruitingNCT05707273Phase 1
• A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic LeukemiaCompletedNCT05672355Phase 2
• Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer SurvivorsWithdrawnNCT05672342Early Phase 1
• Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior ChemotherapyActive, not recruitingNCT05672316Phase 1/2
• Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's TransformationActive, not recruitingNCT05672173Phase 2
• Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian CancerWithdrawnNCT05672095Phase 1/2
• FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal CancerActive, not recruitingNCT05627635Phase 1/2
• Portable Scalp Cooling System for the Improvement of Chemotherapy-Induced Hair Loss in Patients With Metastatic Breast CancerWithdrawnNCT05533320Not applicable
• Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host DiseaseWithdrawnNCT05515692Early Phase 1
• Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT05441514Phase 1
• A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer SurvivorsActive, not recruitingNCT05428176Not applicable
• Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved CommunitiesActive, not recruitingNCT05414396Not applicable
• Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung CancerActive, not recruitingNCT05384769Not applicable
• TMLI and Alemtuzumab for Treatment of Sickle Cell DiseaseActive, not recruitingNCT05384756Phase 1
• Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell TransplantsActive, not recruitingNCT05364762Phase 2
• Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast CancerActive, not recruitingNCT05340673Phase 1
• 8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid LeukemiaSuspendedNCT05263284Phase 1
• An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal CancerActive, not recruitingNCT05245786Early Phase 1
• Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast CancerWithdrawnNCT05244434Not applicable
• Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With VenetoclaxActive, not recruitingNCT05222984Phase 1
• Family Caregivers in Underserved Populations Providing Complex Cancer CareCompletedNCT05213078Not applicable
• Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS TrialCompletedNCT05205512Not applicable
• Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer SurgeryActive, not recruitingNCT05203627Not applicable
• A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation TherapyActive, not recruitingNCT05173961Not applicable
• Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung CancerActive, not recruitingNCT05166616Phase 1
• CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or RelapsedActive, not recruitingNCT05162976Phase 1
• Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic LeukemiaActive, not recruitingNCT05157971Phase 1
• Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular LymphomaWithdrawnNCT05152459Phase 1/2
• Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma SurvivorsCompletedNCT05142371Not applicable
• Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain TumorsActive, not recruitingNCT05139043Phase 2
• 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT05139004Phase 1
• Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer SurvivorsActive, not recruitingNCT05138991Not applicable
• CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney CancerActive, not recruitingNCT05122546Phase 1
• CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast CancerActive, not recruitingNCT05081492Phase 1
• Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal Nonpharmacological SolutionsCompletedNCT05036408Not applicable
• The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood CancerActive, not recruitingNCT05023993Not applicable
• Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American PatientsActive, not recruitingNCT05014646Phase 2
• CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHLWithdrawnNCT04995536Phase 1
• Telehealth Exercise Platform to Reduce Frailty After Bone Marrow TransplantCompletedNCT04968119Not applicable
• Occupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell CarcinomaWithdrawnNCT04961320Not applicable
• Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell LymphomaActive, not recruitingNCT04939272Phase 1/2
• A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell TransplantationActive, not recruitingNCT04914338Not applicable
• Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic CancerActive, not recruitingNCT04887805Phase 2
• Perception of Cure Among Patients With Metastatic CancerWithdrawnNCT04820894
• A Nurse-Led Intervention for Fear of Progression in Advanced CancerActive, not recruitingNCT04819997Not applicable
• Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced DermatitisCompletedNCT04812197Not applicable
• App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell CancerActive, not recruitingNCT04788095Not applicable
• iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell CarcinomaWithdrawnNCT04688333
• Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological MalignanciesCompletedNCT04681105Phase 1
• SARS-CoV-2 Donor-Recipient Immunity TransferCompletedNCT04666025
• Long Term Follow-Up in Patients With Stage 0-IIIC Breast CancerActive, not recruitingNCT04661982
• Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or MedulloblastomaActive, not recruitingNCT04661384Phase 1
• Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell TransplantationWithdrawnNCT04655391Phase 1

← City of Hope Medical Center overview and focus areas